GRSRX
Price
$52.55
Change
-$0.14 (-0.27%)
Updated
Dec 17 closing price
RRGRX
Price
$7.20
Change
-$0.02 (-0.28%)
Updated
Dec 17 closing price
Ad is loading...

GRSRX vs RRGRX

Header iconGRSRX vs RRGRX Comparison
Open Charts GRSRX vs RRGRXBanner chart's image
Cohen & Steers Global Realty R
Price$52.55
Change-$0.14 (-0.27%)
VolumeN/A
CapitalizationN/A
DWS RREEF Global Real Estate Secc R6
Price$7.20
Change-$0.02 (-0.28%)
VolumeN/A
CapitalizationN/A
GRSRX vs RRGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRSRX vs. RRGRX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRSRX is a Sell and RRGRX is a Hold.

FUNDAMENTALS
Fundamentals
GRSRX has more cash in the bank: 1.92B vs. RRGRX (156M). GRSRX pays higher dividends than RRGRX: GRSRX (2.46) vs RRGRX (1.47). GRSRX was incepted earlier than RRGRX: GRSRX (10 years) vs RRGRX (8 years). RRGRX is a more actively managed with annual turnover of: 82.00 vs. GRSRX (52.00). GRSRX (0) and RRGRX (0) have matching initial minimum investment requirements. RRGRX annual gain was more profitable for investors over the last year : 7.83 vs. GRSRX (5.01). GRSRX return over 5 years is better than : 5.92 vs. RRGRX (-4.10).
GRSRXRRGRXGRSRX / RRGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years8 years-
Gain YTD3.1215.98552%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B156M1,231%
Annual Yield % from dividends2.461.47168%
Returns for 1 year5.017.8364%
Returns for 3 years-12.12-13.9287%
Returns for 5 years5.92-4.10-144%
Returns for 10 years36.30N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR44.41-0.33
-0.74%
UDR
CRESY13.58-0.21
-1.52%
Cresud S.A.C.I.F. y A.
CMND1.27-0.04
-3.05%
Clearmind Medicine
OI10.69-0.46
-4.13%
O-I Glass
APLT1.10-0.05
-4.35%
Applied Therapeutics